These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24163084)

  • 1. Expression and clinical significance of STIP1 in papillary thyroid carcinoma.
    Yuan MH; Zhou RS; She B; Xu HF; Wang JY; Wei LX
    Tumour Biol; 2014 Mar; 35(3):2391-5. PubMed ID: 24163084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of survivin expression and its prognostic value in papillary thyroid carcinoma.
    Selemetjev S; Dencic TI; Marecko I; Jankovic J; Paunovic I; Savin S; Cvejic D
    Pathol Res Pract; 2014 Jan; 210(1):30-4. PubMed ID: 24199968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotinidase is a novel marker for papillary thyroid cancer aggressiveness.
    So AK; Kaur J; Kak I; Assi J; MacMillan C; Ralhan R; Walfish PG
    PLoS One; 2012; 7(7):e40956. PubMed ID: 22911723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of metadherin correlates with malignant pathological features and poor prognostic significance in papillary thyroid carcinoma.
    Li WF; Wang G; Zhao ZB; Liu CA
    Clin Endocrinol (Oxf); 2015 Oct; 83(4):572-80. PubMed ID: 25418110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHI3L1 overexpression is associated with metastasis and is an indicator of poor prognosis in papillary thyroid carcinoma.
    Luo D; Chen H; Lu P; Li X; Long M; Peng X; Huang M; Huang K; Lin S; Tan L; Zhu Y; Chen Z; Ouyang N; Li H
    Cancer Biomark; 2017; 18(3):273-284. PubMed ID: 28009325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USP33 is a Biomarker of Disease Recurrence in Papillary Thyroid Carcinoma.
    Jia M; Guo Y; Lu X
    Cell Physiol Biochem; 2018; 45(5):2044-2053. PubMed ID: 29533940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome.
    Yun JY; Kim YA; Choe JY; Min H; Lee KS; Jung Y; Oh S; Kim JE
    J Clin Pathol; 2014 Feb; 67(2):125-33. PubMed ID: 23986551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of USP22 as an oncogene in papillary thyroid carcinoma.
    Wang H; Li YP; Chen JH; Yuan SF; Wang L; Zhang JL; Yao Q; Li NL; Bian JF; Fan J; Yi J; Ling R
    Tumour Biol; 2013 Jun; 34(3):1635-9. PubMed ID: 23412977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants.
    Chowdhury S; Veyhl J; Jessa F; Polyakova O; Alenzi A; MacMillan C; Ralhan R; Walfish PG
    Oncotarget; 2016 May; 7(22):32318-28. PubMed ID: 27086918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations of HOTAIR expression with pathological stage, CT characteristics and prognosis of patients with papillary thyroid carcinoma.
    Chen X; Jin J; Zheng L; Sheng Y; Sun J
    J BUON; 2021; 26(1):259-265. PubMed ID: 33721460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patients.
    Wang W; Su X; He K; Wang Y; Wang H; Wang H; Zhao Y; Zhao W; Zarnegar R; Fahey TJ; Teng X; Teng L
    Cancer; 2016 Jan; 122(2):198-206. PubMed ID: 26506214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAPILLARY THYROID CANCER IS CHARACTERIZED BY ALTERED EXPRESSION OF GENES INVOLVED IN THE SUMOYLATION PROCESS.
    Tuccilli C; Baldini E; Sorrenti S; Di Gioia C; Bosco D; Ascoli V; Mian C; Barollo S; Rendina R; Coccaro C; Pepe M; Catania A; Bononi M; Tartaglia F; De Antoni E; D'Armiento M; Ulisse S
    J Biol Regul Homeost Agents; 2015; 29(3):655-62. PubMed ID: 26403403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic significance of elevated expression of HBME-1 in papillary thyroid carcinoma.
    Chen YJ; Zhao RM; Zhao Q; Li BY; Ma QY; Li X; Chen X
    Tumour Biol; 2016 Jul; 37(7):8715-20. PubMed ID: 26738867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological and Prognostic Significance of WW Domain Binding Protein 5 Expression in Papillary Thyroid Carcinoma.
    Qian Y; Pan Z; Guo Z; Ge X; Zheng G; Cao J; Huang P; Zhu X; Zhu X; Wen Q; Ge M
    Biomed Res Int; 2019; 2019():1791065. PubMed ID: 31828091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressed Krüppel‑like factor 17 expression induces tumor proliferation, metastasis and a poor prognosis in papillary thyroid carcinoma.
    Ye WC; Gao L; Huang J; Fang XM; Xie G
    Mol Med Rep; 2014 Oct; 10(4):2087-92. PubMed ID: 25109837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamin 2 Is Correlated with Recurrence and Poor Prognosis of Papillary Thyroid Cancer.
    Ren N; Tian Z; Sun H; Lu X
    Med Sci Monit; 2020 Aug; 26():e924590. PubMed ID: 32827429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [High aldehyde dehydrogenase 1A1 (ALDH1A1) expression correlated with risk of lymph node metastasis in papillary thyroid carcinoma].
    Yue C; Zhao X; Tian C; Jin Y; Liu H
    Zhonghua Bing Li Xue Za Zhi; 2015 Jul; 44(7):490-4. PubMed ID: 26705040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of G Protein-Coupled Receptor Kinase 6 (GRK6) Is Associated with Progression and Poor Prognosis of Papillary Thyroid Carcinoma.
    Che X; Zhang G; Zhang X; Xue J
    Med Sci Monit; 2018 May; 24():3540-3548. PubMed ID: 29805156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparity expression of gammaH2AX in papillary thyroid cancer and nodular goiter.
    Hu S; Zhang G; Xu J; Zhu X; Lu X; Jiang L; Wang Q; Hou X; Cao J; Ge M
    Clin Lab; 2014; 60(12):2031-7. PubMed ID: 25651738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of stress-induced phosphoprotein 1 in colorectal cancer and its clinicopathologic significance.
    Zhang Z; Ren H; Yang L; Zhang X; Liang W; Wu H; Huang L; Kang J; Xu J; Zhai E; Cai S; He Y
    Hum Pathol; 2018 Sep; 79():135-143. PubMed ID: 29879402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.